doi: 10.1007/s00210-020-01890-6 Summary Keywords COVID-19, paracetamol, non-steroidal anti-inflammatory drugs, inflammation, oxidative damage, glutathione, antioxidant, risk factors Citation Sestili P and Fimognari C (2020) Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness
Ketoacidosis: Jardiance increases the risk of diabetic ketoacidosis
Muscle loss is not a pharmacological inevitability, but rather the predictable outcome of aggressive weight loss without adequate protein or progressive overload
Temperature: The Most Critical Battleground When it comes to peptide stability, temperature isn't just a factor
Efficacy profile and safety of very low-dose rituximab in patients with Graves orbitopathy